These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25158817)

  • 21. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
    Griffin CA; Hawkins AL; Dvorak C; Henkle C; Ellingham T; Perlman EJ
    Cancer Res; 1999 Jun; 59(12):2776-80. PubMed ID: 10383129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
    Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
    Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity.
    Ono A; Murakami H; Serizawa M; Wakuda K; Kenmotsu H; Naito T; Taira T; Koh Y; Ohde Y; Nakajima T; Endo M; Takahashi T
    Lung Cancer; 2016 Sep; 99():151-4. PubMed ID: 27565932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features.
    Chen ST; Lee JC
    Hum Pathol; 2008 Dec; 39(12):1854-8. PubMed ID: 18701132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory myofibroblastic tumour: a rare entity with wide differential diagnosis.
    Gilani SM; Kowalski PJ
    Pathologica; 2014 Mar; 106(1):1-6. PubMed ID: 24897773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
    J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous neoplasms showing EWSR1 rearrangement.
    Boland JM; Folpe AL
    Adv Anat Pathol; 2013 Mar; 20(2):75-85. PubMed ID: 23399793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin.
    Schoolmeester JK; Sukov WR
    Int J Gynecol Pathol; 2017 May; 36(3):228-229. PubMed ID: 27636888
    [No Abstract]   [Full Text] [Related]  

  • 30. ALK-positive inflammatory myofibroblastic tumor of the abdomen with widespread microscopic multifocality.
    Lorenzi L; Cigognetti M; Medicina D; Pellegrini V; Balzarini P; Cestari R; Facchetti F
    Int J Surg Pathol; 2014 Oct; 22(7):640-4. PubMed ID: 24583837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
    Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
    Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical fibrous histiocytoma of the skin with CD30 and p80/ALK1 positivity and ALK gene rearrangement.
    Szablewski V; Laurent-Roussel S; Rethers L; Rommel A; Van Eeckhout P; Camboni A; Willocz P; Copie-Bergman C; Ortonne N
    J Cutan Pathol; 2014 Sep; 41(9):715-9. PubMed ID: 24666231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF; Tong JH; Yeung KS; Lung RW; Law PP; Chau SL; Kang W; Tong CY; Chow C; Chan AW; Leung LK; Mok TS
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
    Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
    Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory myofibroblastic tumor of the larynx with anaplastic lymphoma kinase (ALK) protein overexpression. A case report.
    Bellezza G; Cavaliere A; Del Sordo R; Sidoni A
    Tumori; 2006; 92(5):449-51. PubMed ID: 17168442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of ALK expression in different human cancer types.
    Tennstedt P; Strobel G; Bölch C; Grob T; Minner S; Masser S; Simon R
    J Clin Pathol; 2014 Jun; 67(6):477-81. PubMed ID: 24478382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis.
    Ishibashi Y; Miyoshi H; Hiraoka K; Arakawa F; Haraguchi T; Nakashima S; Hashiguchi T; Shoda T; Hamada T; Okawa T; Higuchi F; Shiba N; Nagata K; Ohshima K
    Oncol Rep; 2015 Apr; 33(4):1667-74. PubMed ID: 25683346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK rearrangement in a large series of consecutive non-small cell lung cancers: comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment.
    Alì G; Proietti A; Pelliccioni S; Niccoli C; Lupi C; Sensi E; Giannini R; Borrelli N; Menghi M; Chella A; Ribechini A; Cappuzzo F; Melfi F; Lucchi M; Mussi A; Fontanini G
    Arch Pathol Lab Med; 2014 Nov; 138(11):1449-58. PubMed ID: 24885803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade myofibroblastic proliferations of the urinary bladder.
    Alquati S; Gira FA; Bartoli V; Contini S; Corradi D
    Arch Pathol Lab Med; 2013 Aug; 137(8):1117-28. PubMed ID: 23899070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.